Search

everythinglearnresearchcommunity

for

Search:↓

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

The article concludes that early treatment of alopecia is crucial to prevent permanent hair loss.

Accurate diagnosis of cicatricial alopecias requires thorough scalp examination and multiple biopsy techniques.

Accurate diagnosis of hair loss types is crucial for effective treatment.

Trichoscopic examination is crucial for diagnosing congenital triangular alopecia.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

PD‐L1 and PD‐L2 may not effectively control immune activation in alopecia areata.

Trichoscopy helps better understand and manage alopecia areata, improving patient outcomes.

Osteopontin may play a role in alopecia areata, but its levels don't predict treatment success.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

A boy with GAPO syndrome had hair loss similar to male pattern baldness without hormone issues, possibly due to skin or blood vessel problems.

Male pattern baldness is mainly caused by genetics and hormones, treatable with minoxidil and finasteride.

Alopecia areata causes hair loss and affects mental health, with new treatments like JAK inhibitors offering hope.

Alopecia areata causes hair loss and affects mental health, with new treatments like JAK inhibitors offering hope.

Leech therapy might help treat alopecia areata by improving blood flow and immune response.

A new method helps diagnose alopecia areata using specific gene markers and could guide targeted treatments.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

BST2 is highly expressed in certain immune cells in alopecia areata, suggesting a role in the disease.

The treatment improved hair growth and was well-received without side effects.

Vitamin D may help reduce severity and relapse of alopecia areata.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

JAK inhibitors, PRP, and exosomes show promise for hair regrowth in Alopecia Areata.

Baricitinib is a relatively safe and effective treatment for severe alopecia areata.

A five-year-old girl has a harmless, unchanging bald patch on her scalp.

Baricitinib is a promising treatment for severe alopecia areata with minimal side effects.

Allergies, especially dust mite allergy, may worsen alopecia areata, and desensitization could help reduce its severity.

A 12-year-old boy has a rare, harmless hair loss on his chin with no need for treatment.

A man with syphilitic alopecia and neurosyphilis was successfully treated with penicillin, leading to symptom improvement and resolution of hair loss.

A 45-year-old woman with autoimmune diseases experienced patchy hair loss due to alopecia areata, which has no cure but can be treated, with varying success.